» Articles » PMID: 39769073

Study of Microbiota Associated to Early Tumors Can Shed Light on Colon Carcinogenesis

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2025 Jan 8
PMID 39769073
Authors
Affiliations
Soon will be listed here.
Abstract

An increasingly important role for gut microbiota in the initiation and progression of colorectal cancer (CRC) has been described. Even in the early stages of transformation, i.e., colorectal adenomas, changes in gut microbiota composition have been observed, and several bacterial species, such as pks and enterotoxigenic , have been proposed to drive colon tumorigenesis. In recent years, several strategies have been developed to study mucosa-associated microbiota (MAM), which is more closely associated with CRC development than lumen-associated microbiota (LAM) derived from fecal samples. This review summarizes the state of the art about the oncogenic actions of gut bacteria and compares the different sampling strategies to collect intestinal microbiota (feces, biopsies, swabs, brushes, and washing aspirates). In particular, this article recapitulates the current knowledge on MAM in colorectal adenomas and serrated polyps, since studying the intestinal microbiota associated with early-stage tumors can elucidate the molecular mechanisms underpinning CRC carcinogenesis.

References
1.
Hua H, Sun Y, He X, Chen Y, Teng L, Lu C . Intestinal Microbiota in Colorectal Adenoma-Carcinoma Sequence. Front Med (Lausanne). 2022; 9:888340. PMC: 9348271. DOI: 10.3389/fmed.2022.888340. View

2.
Wilson M, Jiang Y, Villalta P, Stornetta A, Boudreau P, Carra A . The human gut bacterial genotoxin colibactin alkylates DNA. Science. 2019; 363(6428). PMC: 6407708. DOI: 10.1126/science.aar7785. View

3.
Burns M, Montassier E, Abrahante J, Priya S, Niccum D, Khoruts A . Colorectal cancer mutational profiles correlate with defined microbial communities in the tumor microenvironment. PLoS Genet. 2018; 14(6):e1007376. PMC: 6028121. DOI: 10.1371/journal.pgen.1007376. View

4.
Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag C, Laversanne M . Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023; 72(2):338-344. DOI: 10.1136/gutjnl-2022-327736. View

5.
Ianiro G, Bibbo S, Porcari S, Settanni C, Giambo F, Curta A . Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center. Gut Microbes. 2021; 13(1):1994834. PMC: 8555518. DOI: 10.1080/19490976.2021.1994834. View